Framycetin is a tetracyclic antibacterial agent derived from neomycin, being a glycoside ester of neamine and neobiosamine B. Among its listed roles, it functions as a antibacterial drug, an allergen and an Escherichia coli metabolite. It is the conjugate base of framycetin(6+). It is grouped under the following drug class(es): Aminoglycosides. Its therapeutic use is listed as anti-infectives, antibacterials and antibiotics. The directory classifies it as a commercial API with a fermentation-derived source/manufacturing origin. Other names for this substance include Fradiomycin, Neomas, Nivemycin and Myacyne. Its PubChem CID is 8378.
Neomycin
| CAS No | 119-04-0 |
|---|---|
| Molecular Formula | C23H46N6O13 |
| Molecular Weight | 614.6 g/mol |
| Synonyms | (2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Framycetin is a tetracyclic antibacterial agent derived from neomycin, being a glycoside ester of neamine and neobiosamine B. Among its listed roles, it functions as a antibacterial drug, an allergen and an Escherichia coli metabolite.
The listed CAS number is 119-04-0.
The listed molecular formula is C23H46N6O13.
The listed molecular weight is 614.6 g/mol.
(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol.
The source lists Fradiomycin, Neomas, Nivemycin and Myacyne.